An effective method for adenoviral-mediated delivery of small interfering RNA into mesenchymal stem cells

Journal of Cellular Biochemistry

Volumn 100, Issue 2, 2007, Pages 293-302

  Forte, Amalia ^a   Napolitano, Marco A ^a   Cipollaro, Marilena ^a   Giordano, Antonio ^b   Cascino, Antonino ^a   Galderisi, Umberto ^a,b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Temple University   (United States)

Author keywords

Adenoviral vector; Coxsackie B and adenovirus receptor; Mesenchymal stem cells; Rb2 p130; Serotype 5; Small interfering RNA

Indexed keywords

ADENOVIRUS VECTOR; MESSENGER RNA; PROTEIN P130; RB2 PROTEIN; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADENOVIRUS; ADENOVIRUS 5; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL BASED GENE THERAPY; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL VIABILITY; CONTROLLED STUDY; CYTOLOGY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KNOCKOUT GENE; MESENCHYMAL STEM CELL; MULTIPLICITY OF INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RNA INTERFERENCE; SEROTYPE; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION;

ADENOVIRIDAE; ANIMALS; CELLS, CULTURED; MESENCHYMAL STEM CELLS; RATS; RATS, INBRED WKY; RETINOBLASTOMA-LIKE PROTEIN P130; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

ADENOVIRIDAE; RATTUS;

EID: 33846428066     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21025     Document Type: Article

References (40)

1. Bello LJ, Ginsberg HS. 1967. Inhibition of host protein synthesis in type 5 adenovirus-infected cells. J Virol 1:843-850.
2. Beltz GA, Flint SJ. 1979. Inhibition of HeLa cell protein synthesis during adenovirus infection. Restriction of cellular messenger RNA sequences to the nucleus. J Mol Biol 131:353-373.
3. Caillaud C, Akli S, Vigne E, Koulakoff A, Perricaudet M, Poenaru L, Kahn A, Berwald-Netter Y. 1993. Adenoviral vector as a gene delivery system into cultured rat neuronal and glial cells. Eur J Neurosci 5:1287-1291.
4. Claudio PP, De Luca A, Howard CM, Baldi A, Firpo EJ, Koff A, Paggi MG, Giordano A. 1996. Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res 56:2003-2008.
5. Conget PA, Minguell JJ. 2000. Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells. Exp Hematol 28:382-390.
6. Easton RM, Johnson EM, Creedon DJ. 1998. Analysis of events leading to neuronal death after infection with E1-deficient adenoviral vectors. Mol Cell Neurosci 11:334-347.
7. Fire A, Albertson D, Harrison SW, Moerman DG. 1991. Production of antisense RNA leads to effective and specific inhibition of gene expression in C. elegans muscle. Development 113:503-514.
8. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-811.
9. Forte A, Cipollaro M, Cascino A, Galderisi U. 2005. Small interfering RNAs and antisense oligonucleotides for treatment of neurological diseases. Curr Drug Targets 6:21-29.
10. Friedenstein AJ, Gorskaja JF, Kulagina NN. 1976. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4:267-274.
11. Galderisi U, Di Bernardo G, Cipollaro M, Jori FP, Piegari E, Cascino A, Peluso G, Melone MA. 1999. Induction of apoptosis and differentiation in neuroblastoma and astrocytoma cells by the overexpression of Bin1, a novel Myc interacting protein. J Cell Biochem 74:313-322.
12. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. 2001. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169:12-20.
13. Harborth J, Elbashir SM, Bechert K, Tuschl T, Weber K. 2001. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci 114:4557-4565.
14. Hoelters J, Ciccarella M, Drechsel M, Geissler C, Gulkan H, Bocker W, Schieker M, Jochum M, Neth P. 2005. Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells. J Gene Med 7:718-728.
15. Hung SC, Lu CY, Shyue SK, Liu HC, Ho LL. 2004. Lineage differentiation-associated loss of adenoviral susceptibility and Coxsackie-adenovirus receptor expression in human mesenchymal stem cells. Stem Cells 22:1321-1329.
16. Jacob D, Davis J, Zhu H, Zhang L, Teraishi P, Wu S, Marini FC III, Fang B. 2004. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter. Clin Cancer Res 10:3535-3541.
17. Johnson DG. 1995. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene 11:1685-1692.
18. Jori FP, Napolitano MA, Melone MA, Cipollaro M, Cascino A, Giordano A, Galderisi U. 2004. Role of RB and RB2/P130 genes in marrow stromal stem cells plasticity. J Cell Physiol 200:201-212.
19. Jori FP, Melone MA, Napolitano MA, Cipollaro M, Cascino A, Giordano A, Galderisi U. 2005. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells. Cell Death Differ 12:65-77.
20. Knaan-Shanzer S, van de Watering MJ, van der Velde I, Goncalves MA, Valerio D, de Vries AA. 2005. Endowing human adenovirus serotype 5 vectors with fiber domains of species B greatly enhances gene transfer into human mesenchymal stem cells. Stem Cells 23:1598-1607.
21. Li BJ, Tang Q, Cheng D, Qin C, Xie FY, Wei Q, Xu J, Liu Y, Zheng BJ, Woodle MC, Zhong N, Lu PY. 2005. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat Med 11:944-951.
22. Meister G, Tuschl T. 2004. Mechanisms of gene silencing by double-stranded RNA. Nature 431:343-349.
23. Mizuguchi H, Sasaki T, Kawabata K, Sakurai F, Hayakawa T. 2005. Fiber-modified adenovirus vectors mediate efficient gene transfer into undifferentiated and adipogenic-differentiated human mesenchymal stem cells. Biochem Biophys Res Commun 332:1101-1106.
24. Noth U, Schupp K, Heymer A, Kall S, Jakob F, Schutze N, Baumann B, Barthel T, Eulert J, Hendrich C. 2005. Anterior cruciate ligament constructs fabricated from human mesenchymal stem cells in a collagen type I hydrogel. Cytotherapy 7:447-455.
25. Olmsted-Davis EA, Gugala Z, Gannon FH, Yotnda P, McAlhany RE, Lindsey RW, Davis AR. 2002. Use of a chimeric adenovirus vector enhances BMP2 production and bone formation. Hum Gene Ther 13:1337-1347.
26. Paddison PJ, Caudy AA, Sachidanandam R, Hannon GJ. 2004. Short hairpin activated gene silencing in mammalian cells. Methods Mol Biol 265:85-100.
27. Peister A, Mellad JA, Wang M, Tucker HA, Prockop DJ. 2004. Stable transfection of MSCs by electroporation. Gene Ther 11:224-228.
28. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
29. Prockop DJ. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
30. Prockop DJ. 1998. Marrow stromal cells as stem cells for continual renewal of nonhematopoietic tissues and as potential vectors for gene therapy. J Cell Biochem Suppl 30-31:284-285.
31. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. 2004. Rational siRNA design for RNA interference. Nat Biotechnol 22:326-330.
32. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. 2005. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23:220-229.
33. Shi Y. 2003. Mammalian RNAi for the masses. Trends Genet 19:9-12.
34. Stiegler P, Kasten M, Giordano A. 1998. The RB family of cell cycle regulatory factors. J Cell Biochem Suppl 30-31:30-36.
35. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M. 2002. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62:3603-3608.
36. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. 2002. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105:93-98.
37. Tsuda H, Wada T, Ito Y, Uchida H, Dehari H, Nakamura K, Sasaki K, Kobune M, Yamashita T, Hamada H. 2003. Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol Ther 7:354-365.
38. Tuan RS, Boland G, Tuli R. 2003. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 5:32-45.
39. Wersto RP, Rosenthal ER, Seth PK, Eissa NT, Donahue RE. 1998. Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins. J Virol 72:9491-9502.
40. Xia H, Mao Q, Paulson HL, Davidson BL. 2002. siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 20:1006-1010.